tirzepatide for iih GLP-1 medications and pseudotumor cerebri / idiopathic intracranial hypertension #pseudotumorcerebri #iih Use of glucagon-like peptide-1 receptor

Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis

95% CI, 0.38 to 1.16

Some people experience a lag between their physical transformation and their mental self-image

Miss this detail and you are either underdosing (wasting time and money) or overdosing (risking nausea, vomiting, and side effects that could have been avoided entirely)

FDAs Compounded Drug Products That Are Essentially Copies of Approved Drug Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act guidance states the following: FDA does not intend to take action against an outsourcing facility for filling orders that it received for a compounded drug that is identical, or nearly identical, to an approved drug that was on FDAs drug shortage list at the time that the outsourcing facility received the order, provided the drug also appeared on the FDA drug shortage list within 60 days of the outsourcing facility distributing or dispensing the drug